The effects of chronic smoking on the fibrinolytic potential of plasma and platelets

British Journal of Haematology

Volumn 97, Issue 1, 1997, Pages 208-213

  Simpson, A J ^a,c   Gray, R S ^a   Moore, N R ^b   Booth, N A ^b  

^a ST JOHN'S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

plasma; plasminogen activator inhibitor type 1; platelets; smoking; tissue type plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; THROMBOCYTE;

EID: 0030990903     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2137.x     Document Type: Article

References (30)

1. Allen, R.A., Kluft, C. & Brommer, E.J.P. (1985) Effect of chronic smoking on fibrinolysis. Arteriosclerosis, 5, 443-450.
2. Asplund-Carlson, A., Hamsten, A., Wiman, B. & Carlson, L.A. (1993) Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia, 36, 817-825.
3. Belch, J.J.F., McArdle, B.M., Burns, P., Lowe, G.D.O. & Forbes, C.D. (1984) The effects of acute smoking on platelet behaviour, fibrinolysis and haemorrheology in habitual smokers. Thrombosis and Haemoatasis, 51, 6-8.
4. Booth, N.A. (1994) The natural inhibitors of fibrinolysis. Haemostasis and Thrombosis (ed. by A. L. Bloom and D. P Thomas), pp. 699-717. Churchill Livingstone, Edinburgh.
5. Booth, N.A., Simpson, A.J., Croll, A.M., Bennett, B. & MacGregor, I.R. (1988) Plasminogen activator inhibitor (PAI-1) in plasma and platelets. British Journal of Haematology, 70, 327-333.
6. Chandler, W.L., Trimble, S.L., Loo, S.C. & Mornin, D. (1990) Effect of PAI-1 levels on the molar concentrations of active plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood, 76, 930-937.
7. Chmielewska, J. & Wiman, B. (1986) Determination of tissue plasminogen activator and its "fast" inhibitor in plasma. Clinical Chemistry, 32, 482-485.
8. Craig, W.Y., Palomaki, G.E. & Haddow, J.E. ( 1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. British Medical Journal, 298, 784-788.
9. Dobson, A.J., Alexander, H.M., Heller, R.F. & Lloyd, D.M. (1991) How soon after quitting smoking does risk of heart attack decline? Journal of Clinical Epidemiology, 44, 1247-1253.
10. Dotevall, A., Kutli, J., Teger-Nilsson, A.C., Wadenvik, H. & Wilhelmsen, L. (1987) Platelet reactivity, fibrinogen and smoking. European Journal of Haematology, 38, 55-59.
11. E.C.A.T. Angina Pectoris Study Group (1993) E.C.A.T. angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. European Heart Journal, 14, 8-17.
12. Facchini, F.S., Hollenbeck, C.B., Jeppesen, J., Chen, Y.-D.I. & Reaven, G.M. (1992) Insulin resistance and cigarette smoking. Lancet, 339, 1128-1130.
13. Gris, J.-C., Schved, J.F., Feugas, O., Aguilar-Martinez, P., Arnaud, A., Sanchez, N. & Sariat, C. (1990) Impact of smoking, physical training and weight reduction on FVII, PAI-1 and haemostatic markers in sedentary men. Thrombosis and Haemostasis, 64, 516-520.
14. Haire, W.D., Goldsmith, J.C. & Rasmussen, J. (1989) Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors. American Journal of Hematology, 31, 36-40.
15. Hamsten, A., de Faire, U., Walldius, G., Dahlen, G., Szamosi, A., Landou. C., Blomback, M. & Wiman, B. (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet, ii, 3-9.
16. Juhan-Vague, I., Alessi, M.C., Fossat, C., Declerck, P.J. & Kruithof, E.K.O. (1987a) Plasma determination of plasminogen activator inhibitor 1 antigen must be performed in blood collected on antiplatelet/anticoagulant mixture. Thrombosis and Haemostasis, 58, 1096.
17. Juhan-Vague, I., Alessi, M.C. & Vague, P. (1991) Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia, 34, 457-462.
18. Juhan-Vague, I., Valadier, J., Alessi, M.C., Aillaud, M.E. Ansaldi, J., Philip-Joet, C., Holvoet, P., Serradimigni, A. & Collen, D. (1987b) Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thrombosis and Haemostasis, 57, 67-72.
19. Kjaeldgaard, A. & Larsson, B. (1986) Long-term treatment with combined oral contraceptives and cigarette smoking associated with impaired activity of tissue plasminogen activator. Acta Obstetrica et Gynecologica Scandinavica, 65, 219-222.
20. MacGregor, I.R. & Booth, N.A. (1988) An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1). Thrombosis and Haemostasis, 59, 68-72.
21. MacGregor, I.R., MacDonald, S., Dawes, J., Micklem, L.R. & James, K. (1987) A monoclonal antibody enzyme linked immunosorbent assay directed towards a fibrin binding region of tissue-type plasminogen activator. Fibrinolysis, 1, 247-252.
22. Meade, T.W., Vickers, M.V., Thompson, S.G., Stirling, Y. Haines, A.P & Miller, G.J. (1985) Epidemiological characteristics of platelet aggregability. British Medical Journal, 290, 428-432.
23. Mehta, J., Mehta, P., Lawson, D. & Goldeen, T. (1987) Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. Journal of the American College of Cardiologists, 9, 263-268.
24. Negri, E., La Vecchia, C., D'Avanzo, B., Nobili, A. & La Malfa, R.G., on behalf of the GISSI-EFRIM investigators (1994) Acute myocardial infarction: association with time since stopping smoking in Italy. Journal of Epidemiology and Community Health, 48, 129-133.
25. Oudenhoven, L.F.I.J., Brommer, E.J.P., Aronson, D.C., Raben, A.M.T.J., Frölich, M. & van Bockel, J.H. (1994) Impaired fibrinolysis in young adults with arterial occlusive disease: the relationship with hyperinsulinism and smoking. Fibrinolysis, 8, 263-269.
26. Özdemir, O., Karaaslan, Y., Özcebe, O., Dunbar, S. & Kiralzi, S. (1992) The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers. Thrombosis Research, 65, 263-274.
27. Rival, J., Riddle, J.M. & Stein, P.D. (1987) Effects of chronic smoking on platelet function. Thrombosis Research, 45, 75-85.
28. Robbie, I.A., Booth, N.A., Croll, A.M. & Bennett, B. (1993) The roles of alpha 2-antiplasmin and plasminogen activator inhibitor (PAI-1) in the inhibition of clot lysis. Thrombosis and Haemostasis, 70, 301-306.
29. Simpson, A.J., Booth, N.A., Moore, N.R. & Bennett, B. (1990) The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. British Journal of Haematology, 75, 543-548.
30. Sprengers, E.D. & Kluft, C. (1987) Plasminogen activator inhibitors. Blood, 69, 381-387.